Literature DB >> 18566081

Recent changes in the management of community acquired pneumonia in adults.

Hannah J Durrington1, Charlotte Summers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18566081      PMCID： PMC2432122          DOI： 10.1136/bmj.a285

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

1.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

Authors:  W S Lim; M M van der Eerden; R Laing; W G Boersma; N Karalus; G I Town; S A Lewis; J T Macfarlane
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  2004 update of BTS pneumonia guidelines: what's new?

Authors:  J T Macfarlane; D Boldy
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

3.  Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.

Authors:  W S Lim; J T Macfarlane; T C Boswell; T G Harrison; D Rose; M Leinonen; P Saikku
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

4.  Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.

Authors:  Graham D Mills; Michael R Oehley; Bruce Arrol
Journal:  BMJ       Date:  2005-01-31

5.  Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.

Authors:  J P Metlay; W N Kapoor; M J Fine
Journal:  JAMA       Date:  1997-11-05       Impact factor: 56.272

6.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

7.  The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study.

Authors:  M J Fine; L J Hough; A R Medsger; Y H Li; E M Ricci; D E Singer; T J Marrie; C M Coley; M B Walsh; M Karpf; K C Lahive; W N Kapoor
Journal:  Arch Intern Med       Date:  1997-01-13

8.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

9.  Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

Authors:  Peter M Houck; Dale W Bratzler; Wato Nsa; Allen Ma; John G Bartlett
Journal:  Arch Intern Med       Date:  2004-03-22

Review 10.  Community-acquired pneumonia.

Authors:  Thomas M File
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321
View more
  5 in total

1.  What about viral community acquired pneumonias?

Authors:  G Y Shin
Journal:  BMJ       Date:  2008-07-01

2.  Diagnostic Performance of Multiplex Nucleic Acid Testing of Bronchoalveolar Lavage and Bronchial Wash Specimens for Respiratory Viral Pathogens.

Authors:  Satish Munigala; C A Burnham; Neil W Anderson; Stephen Y Liang; Steven J Lawrence; David K Warren
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

3.  Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.

Authors:  Paul Krueger; Oona St Amant; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-06-30       Impact factor: 3.921

Review 4.  Viral pneumonia.

Authors:  Olli Ruuskanen; Elina Lahti; Lance C Jennings; David R Murdoch
Journal:  Lancet       Date:  2011-03-22       Impact factor: 79.321

Review 5.  Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with community-acquired pneumonia: a meta-analysis.

Authors:  Xiaodong Wu; Qin Wang; Min Wang; Xin Su; Zheng Xing; Weiyun Zhang; Yi Shi
Journal:  Respiration       Date:  2015-03-12       Impact factor: 3.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.